Sugammadex
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06206 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | breast fibrocystic disease | KG + DL |
| 2 | Prinzmetal angina | KG + DL |
| 3 | peripheral arterial disease | KG + DL |
| 4 | apocrine adenosis of breast | KG + DL |
| 5 | blunt duct adenosis of breast | KG + DL |
| 6 | thrombotic disease | KG + DL |
| 7 | tendinitis | KG + DL |
| 8 | antithrombin deficiency type 2 | KG + DL |
| 9 | benign mammary dysplasia | KG + DL |
| 10 | female breast carcinoma | KG + DL |
| 11 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 12 | epiglottitis | KG + DL |
| 13 | ischemic disease | KG + DL |
| 14 | angiodysplasia | KG + DL |
| 15 | myositis fibrosa | KG + DL |
| 16 | idiopathic granulomatous myositis | KG + DL |
| 17 | hemoglobinopathy | KG + DL |
| 18 | fibrocartilaginous embolism | KG + DL |
| 19 | venous thromboembolism | KG + DL |
| 20 | breast adenosis | KG + DL |
| 21 | heparin cofactor 2 deficiency | KG + DL |
| 22 | peripheral vascular disease | KG + DL |
| 23 | non-inflammatory vasculopathy | KG + DL |
| 24 | lactation disease | KG + DL |
| 25 | vascular ectasia | KG + DL |
| 26 | congenital renal artery stenosis | KG + DL |
| 27 | breast abscess | KG + DL |
| 28 | fat necrosis of breast | KG + DL |
| 29 | fibromyalgia | KG + DL |
| 30 | vein disease | KG + DL |
| 31 | thrombophilia | KG + DL |
| 32 | intermittent vascular claudication | KG + DL |
| 33 | myocardial infarction | KG + DL |
| 34 | laryngitis | KG + DL |
| 35 | malignant pleural mesothelioma | KG + DL |
| 36 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 37 | Lyme disease | KG + DL |
| 38 | coronary thrombosis | KG + DL |
| 39 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 40 | beta-thalassemia with other manifestations | KG + DL |
| 41 | posteroinferior myocardial infarction | KG + DL |
| 42 | posterolateral myocardial infarction | KG + DL |
| 43 | septal myocardial infarction | KG + DL |
| 44 | inclusion body myositis | KG + DL |
| 45 | intracranial arteriosclerosis | KG + DL |
| 46 | vascular insufficiency disorder | KG + DL |
| 47 | priapism | KG + DL |
| 48 | malignant epithelioid mesothelioma | KG + DL |
| 49 | pyropoikilocytosis, hereditary | KG + DL |
| 50 | malignant visceral pleura tumor | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.